Physician profile
Ayodele Osowo
NPI 1063552479
$6,785.61
in general payments reported to CMS, 2019-2025
36 companies · $762 in 2025
The $762 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,077 · 2020: $869 · 2021: $1,090 · 2022: $983 · 2023: $1,051 · 2024: $954 · 2025: $762.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,706 · Education: $60.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,706.27 |
| Education | $60.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,727.67 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $631.10 | 2019-2024 | Entyvio |
| Janssen Biotech, INC. | $562.08 | 2019-2025 | Stelara, Remicade, Simponi Aria |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $412.30 | 2019-2023 | Trulance |
| Gilead Sciences, INC. | $251.20 | 2019-2024 | |
| Qol Medical, LLC | $249.78 | 2019-2025 | Sucraid |
| Celgene Corporation | $230.89 | 2021-2024 | Zeposia |
| Regeneron Healthcare Solutions, INC. | $230.64 | 2023-2025 | Dupixent |
| Merck Sharp & Dohme LLC | $186.82 | 2019-2024 | Dificid |
| Ironwood Pharmaceuticals, INC | $165.92 | 2019-2021 | |
| Genzyme Corporation | $150.46 | 2023-2024 | |
| Redhill Biopharma INC. | $99.64 | 2020-2023 | Talicia |
| Boston Scientific Corporation | $82.96 | 2019 | |
| Braintree Laboratories, INC. | $80.24 | 2021-2022 | |
| Sandoz INC. | $74.02 | 2023 | Hyrimoz |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $72.49 | 2024-2025 | Omvoh |
| Allergan, INC. | $61.39 | 2019-2020 | |
| Evoke Pharma, INC. | $54.07 | 2022 | |
| Ardelyx, INC. | $47.11 | 2023-2024 | Ibsrela |
| Ferring Pharmaceuticals INC. | $45.24 | 2023-2025 | Clenpiq, Rebyota |
| Intercept Pharmaceuticals, INC. | $44.09 | 2019 | |
| Nestle Healthcare Nutrition INC. | $33.60 | 2022-2023 | |
| Madrigal Pharmaceuticals | $32.89 | 2025 | Rezdiffra |
| Cook Medical LLC | $32.04 | 2024 | Hemospray |
| Pacira Pharmaceuticals Incorporated | $28.16 | 2019 | |
| Ambu INC. | $22.32 | 2020 | |
| Ipsen Biopharmaceuticals, INC | $20.69 | 2024 | Bylvay |
| Shionogi INC | $20.57 | 2020 | |
| Alexion Pharmaceuticals, INC. | $20.29 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $20.20 | 2021 | |
| Pfizer INC. | $19.92 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.37 | 2023 | |
| Endo Pharmaceuticals INC. | $17.33 | 2020 | |
| Aimmune Therapeutics, INC. | $14.78 | 2024 | |
| Vivus LLC | $13.77 | 2021 | |
| Micro-Tech Endoscopy USA, INC. | $11.57 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ayodele Osowo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.